Summary
Latest filing:
Axel Bolte files SEC Form 4 reports at Inozyme Pharma, Inc. (INZY). 1 SEC Form 4 filing on record, dated 1 July 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Axel Bolte has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Axel Bolte's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- GIC Private Ltd - $812.73M of MDLN open-market activity in the last 12 months
- Martine A. Rothblatt - $750.95M of UTHR open-market activity in the last 12 months
- TPG GP A, LLC - $742.97M of LFST open-market activity in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M of SHC open-market activity in the last 12 months
- Keith A. Meister - $591.13M of ILMN open-market activity in the last 12 months
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Axel Bolte?
Axel Bolte is a corporate insider of Inozyme Pharma, Inc. (INZY). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Axel Bolte last file a Form 4?
The only primary Form 4 on record is dated 1 July 2025.
Where can I see all of Axel Bolte's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Axel Bolte and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
